Company Case Study by ADM | Taking microbiome innovation from lab to life: Clinical evidence demonstrates how postbiotics can support allergy symptoms

Dr Richard Day will present an innovative new clinical study demonstrating how a heat-treated whole cell postbiotic delivered meaningful improvements in allergy symptom and quality of life scores for adults with allergic rhinitis. These findings are some of the first successful clinical trial results for a postbiotic in this population.

Explore ADM's rapidly growing postbiotic pipeline, as well as emerging evidence showcasing how microbiome-driven innovation can help reshape the health of people and pets.

By viewing this session, the sponsor may contact you with product and service information. You can unsubscribe or contact the sender anytime. See the Privacy Policy (https://privacy.informa.com/policies/en/) for details.

This session will be recorded on site and will be made available for on-demand viewing from 11th May till 8th June 2026.